Oral immunotherapy for multiple foods in a pediatric allergy clinic setting

被引:28
作者
Eapen, Amy A. [1 ]
Lavery, William J. [1 ]
Siddiqui, Jaweriah S. [1 ]
Lierl, Michelle B. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA
关键词
TREE NUT ALLERGY; EOSINOPHILIC ESOPHAGITIS; PEANUT; PREVALENCE; CHILDREN;
D O I
10.1016/j.anai.2019.08.463
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The increasing incidence of pediatric food allergy results in significant health care burden and family stress. Oral immunotherapy (OIT) can induce tolerance to peanut, milk, and egg. OIT for other foods, particularly multiple foods simultaneously, has not been thoroughly studied. Objective: To summarize our experience with OIT for multiple foods in a pediatric allergy clinic setting. Methods: Medical records were reviewed for patients undergoing OIT for multiple foods. Methods and outcomes of OIT were summarized. Outcomes were analyzed for correlation with baseline food allergen skin prick tests (SPTs) and specific IgE (sIgE) test results. Results: Forty-five patients aged 1.5 to 18 years undertook OIT for up to 12 foods, including peanut, tree nuts, seeds, legumes, and egg. At the time of review, 35 patients were receiving daily maintenance dosing, 4 had completed OIT and were continuing to eat their foods 3 times weekly, and 6 had stopped OIT because of anxiety, inconvenience, or allergy symptoms. A total of 49% of patients had reactions during the up-dosing process, mostly oral itching (33%), perioral hives (40%), and abdominal pain (35%). There was no correlation of baseline skin prick test (SPT) and sIgE test results with reaction threshold for baseline food challenge, lowest dose causing reactions during up-dosing, or time to reach maintenance. Higher baseline sIgE level but not baseline SPT result was associated with an increased number of allergic reactions during OIT. Baseline SPT correlated with stopping OIT. Conclusion: A similar approach to that used for peanut OIT can be taken for nonpeanut foods and for multiple foods simultaneously. High baseline allergy test results are not a contraindication to OIT. (C) 2019 American College of Allergy, Asthma & Immunology.
引用
收藏
页码:573 / +
页数:12
相关论文
共 31 条
[1]   The Epidemiology of IgE-Mediated Food Allergy and Anaphylaxis [J].
Allen, Katrina J. ;
Koplin, Jennifer J. .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2012, 32 (01) :35-+
[2]   Anaphylaxis in Children: Epidemiology, Risk Factors and Management [J].
Anagnostou, Katherine .
CURRENT PEDIATRIC REVIEWS, 2018, 14 (03) :180-186
[3]   Feasibility of sustained response through long-term dosing in food allergy immunotherapy [J].
Andorf, Sandra ;
Manohar, Monali ;
Dominguez, Tina ;
Block, Whitney ;
Tupa, Dana ;
Kshirsagar, Rohun A. ;
Sampath, Vanitha ;
Chinthrajah, R. Sharon ;
Nadeau, Kari C. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
[4]   Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab [J].
Andorf, Sandra ;
Manohar, Monali ;
Dominguez, Tina ;
Block, Whitney ;
Tupa, Dana ;
Kshirsagar, Rohun A. ;
Sampath, Vanitha ;
Chinthrajah, R. Sharon ;
Nadeau, Kari C. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
[5]   Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial [J].
Andorf, Sandra ;
Purington, Natasha ;
Block, Whitney M. ;
Long, Andrew J. ;
Tupa, Dana ;
Brittain, Erica ;
Spergel, Amanda Rudman ;
Desai, Manisha ;
Galli, Stephen J. ;
Nadeau, Kari C. ;
Chinthrajah, R. Sharon .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (02) :85-94
[6]  
[Anonymous], NIH PUBL
[7]  
[Anonymous], 2014, LANCET, DOI DOI 10.1016/S0140-6736(13)62301-6
[8]   Safety and feasibility of oral immunotherapy to multiple allergens for food allergy [J].
Begin, Philippe ;
Winterroth, Lisa C. ;
Dominguez, Tina ;
Wilson, Shruti P. ;
Bacal, Liane ;
Mehrotra, Anjuli ;
Kausch, Bethany ;
Trela, Anthony ;
Hoyte, Elisabeth ;
O'Riordan, Gerri ;
Seki, Scott ;
Blakemore, Alanna ;
Woch, Margie ;
Hamilton, Robert G. ;
Nadeau, Kari C. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
[9]   Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab [J].
Begin, Philippe ;
Dominguez, Tina ;
Wilson, Shruti P. ;
Bacal, Liane ;
Mehrotra, Anjuli ;
Kausch, Bethany ;
Trela, Anthony ;
Tavassoli, Morvarid ;
Hoyte, Elisabeth ;
O'Riordan, Gerri ;
Blakemore, Alanna ;
Seki, Scott ;
Hamilton, Robert G. ;
Nadeau, Kari C. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
[10]   Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab [J].
Burk, Caitlin M. ;
Dellon, Evan S. ;
Steele, Pamela H. ;
Virkud, Yamini V. ;
Kulis, Mike ;
Burks, Wesley ;
Vickery, Brian P. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (02) :498-501